domingo, 3 de agosto de 2014

Ahead of Print -Ongoing Epidemic of Cutaneous Leishmaniasis among Syrian Refugees, Lebanon - Volume 20, Number 10—October 2014 - Emerging Infectious Disease journal - CDC

full-text ►

Ahead of Print -Ongoing Epidemic of Cutaneous Leishmaniasis among Syrian Refugees, Lebanon - Volume 20, Number 10—October 2014 - Emerging Infectious Disease journal - CDC


Volume 20, Number 10—October 2014


Ongoing Epidemic of Cutaneous Leishmaniasis among Syrian Refugees, Lebanon

Maya Saroufim, Khalil Charafeddine, Grace Issa, Haifaa Khalifeh, Robert H. Habib, Atika Berry, Nada Ghosn, Alissar Rady, and Ibrahim KhalifehComments to Author 
Author affiliations: American University of Beirut Medical Center, Beirut, Lebanon (M. Saroufim, K. Charafeddine, G. Issa, H. Khalifeh, R.H. Habib, I. Khalifeh)Ministry of Public Health, Beirut (A. Berry, N. Ghosn)World Health Organization, Beirut (A. Rady)


In September 2012, a cutaneous leishmaniasis outbreak began among Syrian refugees in Lebanon. For 948 patients in whom leishmaniasis was not confirmed, we obtained samples for microscopic confirmation and molecular speciation. We identified Leishmania tropica in 85% and L. major in 15% of patients. After 3 months of megulamine antimonite therapy, patients initial cure rate was 82%.
The Syrian population has been affected by the protracted conflict and ongoing insecurity in the Middle East. The United Nations High Commissioner for Refugees estimates that >4.1 million refugees have been displaced into temporary settlements in neighboring countries, including 1.5 million into Lebanon (1,2). Persons in these temporary settlements are affected by inadequate sanitation, lack of access to clean water, overcrowding, and increased exposure to disease.
Leishmaniasis is a parasitic disease comprising a wide spectrum of chronic infections in humans and in certain animal species. It is caused by ≈20 species of Leishmania protozoa; is distributed worldwide; and affects millions of persons in parts of Asia, Africa, South America, and the Mediterranean Basin. The global incidence is ≈1.5–2 million cases per year, and the disease primarily affects children (3). Leishmaniasis is a major public health concern in the eastern Mediterranean region, which bears the brunt of the worldwide prevalence (≈57%), and is endemic to 16 of the 23 countries in this region, and Afghanistan, Iraq, and the Syrian Arab Republic are among the hot spots of leishmaniasis (4).
The 3 major forms of leishmaniasis (cutaneous, mucocutaneous, and visceral) are transmitted by the bite of the female sandfly (5). L. major, the most widely endemic disease-causing species, is closely tied to the semiarid climate zone (6). L. tropica is found in countries in northern Africa, central Asia, and the Middle East, including northern Syria (Aleppo) (7). Aleppo is one of the most cutaneous leishmaniasis–endemic areas in the world; ≈12,000 new cases occur each year (8). We have documented a cutaneous leishmania outbreak among Syrian refugees within the Lebanese borders that began in September 2012 and is ongoing.

The Study

The institutional review board of the American University of Beirut approved this study. In November 2012, one of us (I.K.) began documenting the epidemic during trips to multiple refugee camps in eastern Lebanon (the Bekaa Valley [Baalbek, Zahle, and Ersaal]); the epidemic later expanded to camps throughout the country. During the study, 1,275 patients from 213 displaced families were triaged into 3 groups: l) leishmaniasis diagnosed, confirmed, and partially treated; 2) leishmaniasis diagnosed, confirmed, but not treated; and 3) leishmaniasis not diagnosed. The first 2 groups comprised 55 families; the remaining 158 families (948 persons) were triaged for diagnosis confirmation and are included in the subsequent statistical analyses. Data were collected at the refugee camps and included punch biopsy specimens for 1 patient/family. We used punch biopsy for microscopic confirmation and for molecular analysis by PCR using a previously published protocol (9). The anatomic sites for biopsy were selected on the basis of appropriate recommendations for sampling (10).
Thumbnail of Migration patterns of refugees from various cities in Syria to different regions in Lebanon, 2012. Most refugees fled from Aleppo, Syria, where leishmaniasis is endemic.
Figure 1. Migration patterns of refugees from various cities in Syria to different regions in Lebanon, 2012Most refugees fled from Aleppo, Syria, where leishmaniasis is endemic.
The average age of patients was 17.6 years; most (80%) patients were <18 years of age. Each family comprised 3–13 members (mean 6), and the percentage of family members infected ranged from 8% to 100% (mean 52%). The refugees had fled from areas to which leishmaniasis is endemic and nonendemic. Most of the refugees we encountered had migrated from Aleppo (74 [67%] patients), followed by Homos (30 [27%] patients) and Damascus (6 [5%] patients). Only 1 Lebanese resident with no history of travel during the past 5 years had leishmaniasis. Our sample population was scattered predominately among 4 regions of Lebanon (Figure 1).
The refugees in our study had been in Lebanon for 1–24 months (mean 5 months) and reported that the first time they saw a cutaneous lesions was 1–27 months (mean 5 months) before being examined. Most (77%) patients reported the appearance of the first lesion after being in Lebanon for >2 months, and 53% of patients recalled history of an antecedent insect bite. The head and neck were the most common locations for the cutaneous lesion (43% of patients), followed by the upper extremities (26%) and lower extremities (11%). Patients had 1–15 lesions (mean 3). Lesion size ranged from 1 cm to 15 cm (average 2.6 cm). Verrucous lesions, with or without ulceration, were the most common lesion type (56%), followed by plaque/nodular lesions (43%) and papular lesions (2%). Most patients (83%) had dry lesions; 7 persons (4%) had primary wet lesions, and 12 (8%) had both. All patients had active lesions without evidence of healing or scarring. Speciation by PCR yielded L. tropica in 85% of patients and L. major in 15%.

No hay comentarios:

Publicar un comentario